Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
View ORCID ProfileSíle A Johnson, Eloise Phillips, Sandra Adele, Stephanie Longet, Tom Malone, Chris Mason, Lizzie Stafford, Anni Jamsen, Siobhan Gardiner, Alexandra Deeks, Janice Neo, Emily J Blurton, Jemima White, Muhammed Ali, Barbara Kronsteiner-Dobramysl, Dónal T Skelly, Katie Jeffery, Christopher P Conlon, Philip Goulder, PITCH Consortium, Miles Carroll, Eleanor Barnes, Paul Klenerman, Susanna J Dunachie
doi: https://doi.org/10.1101/2022.09.03.22279558
Síle A Johnson
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
2University of Oxford Medical School, University of Oxford, Oxford, UK
3University Hospital of Derby and Burton, UK
Eloise Phillips
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Sandra Adele
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
4Oxford Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
5Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
Stephanie Longet
6Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
7Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK
Tom Malone
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Chris Mason
2University of Oxford Medical School, University of Oxford, Oxford, UK
Lizzie Stafford
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
9Department of Experimental Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Anni Jamsen
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
9Department of Experimental Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Siobhan Gardiner
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
9Department of Experimental Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Alexandra Deeks
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
9Department of Experimental Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Janice Neo
3University Hospital of Derby and Burton, UK
Emily J Blurton
3University Hospital of Derby and Burton, UK
Jemima White
2University of Oxford Medical School, University of Oxford, Oxford, UK
Muhammed Ali
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
4Oxford Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
5Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
Barbara Kronsteiner-Dobramysl
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
4Oxford Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Dónal T Skelly
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
10Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Katie Jeffery
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
11Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Christopher P Conlon
4Oxford Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Philip Goulder
12Peter Medawar Building for Pathogen Research, Department of Paediatrics, University of Oxford, Oxford, UK
Miles Carroll
6Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
7Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK
Eleanor Barnes
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
13NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
14Translational Gastroenterology Unit, University of Oxford, Oxford, UK
Paul Klenerman
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
13NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
14Translational Gastroenterology Unit, University of Oxford, Oxford, UK
Susanna J Dunachie
1Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
4Oxford Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
5Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
8Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Data Availability
The data underlying this article are available in the article and in its online supplementary material.
Posted September 04, 2022.
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A Johnson, Eloise Phillips, Sandra Adele, Stephanie Longet, Tom Malone, Chris Mason, Lizzie Stafford, Anni Jamsen, Siobhan Gardiner, Alexandra Deeks, Janice Neo, Emily J Blurton, Jemima White, Muhammed Ali, Barbara Kronsteiner-Dobramysl, Dónal T Skelly, Katie Jeffery, Christopher P Conlon, Philip Goulder, PITCH Consortium, Miles Carroll, Eleanor Barnes, Paul Klenerman, Susanna J Dunachie
medRxiv 2022.09.03.22279558; doi: https://doi.org/10.1101/2022.09.03.22279558
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A Johnson, Eloise Phillips, Sandra Adele, Stephanie Longet, Tom Malone, Chris Mason, Lizzie Stafford, Anni Jamsen, Siobhan Gardiner, Alexandra Deeks, Janice Neo, Emily J Blurton, Jemima White, Muhammed Ali, Barbara Kronsteiner-Dobramysl, Dónal T Skelly, Katie Jeffery, Christopher P Conlon, Philip Goulder, PITCH Consortium, Miles Carroll, Eleanor Barnes, Paul Klenerman, Susanna J Dunachie
medRxiv 2022.09.03.22279558; doi: https://doi.org/10.1101/2022.09.03.22279558
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)